Livara Health provides a value-based MSK management solution that combines care planning, virtual-first care delivery, and care navigation. The company uses a biopsychosocial approach across virtual and in-person pathways and reports fewer surgeries, injections, and opioid use versus traditional conservative treatment. Livara has treated over 120,000 people and entered 2024 with nearly 4 million people eligible to access its MSK platform via health plan and provider partnerships, including Medicare and commercial populations. It partners with payors and providers under flexible value-based payment arrangements and can assume the total cost of musculoskeletal care for partners. The new funding will accelerate innovation of Livara’s technology and clinical capabilities to expand its proprietary care delivery model and manage additional risk for partners. Formerly SpineZone and operating for over 17 years, Livara aims to grow all populations served and broaden its clinical programs. SpineZone delivers personalized exercise curricula for neck and back pain through a virtual physical-therapy platform augmented by in-person clinics. Patients answer intake questions via smartphone or laptop and then follow evidence-based exercise videos created with healthcare professionals. The in-person clinics provide hands-on support and help translate a video repository with tracked outcomes into real-world care. The company reports "1 million lives under management" and cites partner results such as a 50% reduction in surgery rate and Sharp Community Medical Group saving $3.4 million over two years. Its business model charges clinics based on members served per month and incorporates shared-upside/shared-downside agreements tied to cost outcomes. SpineZone positions itself against other musculoskeletal digital health startups and is pushing toward greater adoption of value-based care, projecting value-based revenue to reach about 50% in the near future.

Total raised

$27M

Funding rounds

2

Latest round

Series B

Latest activity

May 2024